203 related articles for article (PubMed ID: 10333542)
1. Gonadotropin-releasing hormone agonist has the ability to induce increased matrix metalloproteinase (MMP)-2 and membrane type 1-MMP expression in corpora lutea, and structural luteolysis in rats.
Goto T; Endo T; Henmi H; Kitajima Y; Kiya T; Nishikawa A; Manase K; Sato H; Kudo R
J Endocrinol; 1999 Jun; 161(3):393-402. PubMed ID: 10333542
[TBL] [Abstract][Full Text] [Related]
2. Identical changes in Bax expression, but not Fas ligand expression, occur in structural luteolysis in gonadotropin releasing hormone agonist- and prolactin-treated superovulated rats.
Endo T; Kiya T; Kitajima Y; Honnma H; Chida M; Hayashi T; Henmi H; Yamazaki K; Hayashi T; Manase K; Kudo R
Life Sci; 2005 Mar; 76(19):2159-69. PubMed ID: 15733931
[TBL] [Abstract][Full Text] [Related]
3. Coordinate induction and activation of metalloproteinase and ascorbate depletion in structural luteolysis.
Endo T; Aten RF; Wang F; Behrman HR
Endocrinology; 1993 Aug; 133(2):690-8. PubMed ID: 8344207
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis.
Ricke WA; Smith GW; Smith MF
Biol Reprod; 2002 Mar; 66(3):685-91. PubMed ID: 11870075
[TBL] [Abstract][Full Text] [Related]
5. The significance of membrane type 1 metalloproteinase in structural involution of human corpora lutea.
Manase K; Endo T; Henmi H; Kitajima Y; Yamazaki K; Nishikawa A; Mitaka T; Sato H; Kudo R
Mol Hum Reprod; 2002 Aug; 8(8):742-9. PubMed ID: 12149406
[TBL] [Abstract][Full Text] [Related]
6. The effects of growth hormone on corpus luteum of superovulated rats.
Kiya T; Endo T; Henmi H; Goto T; Kitajima Y; Manase K; Takahashi S; Kudo R
Endocr Res; 1999 May; 25(2):179-93. PubMed ID: 10382680
[TBL] [Abstract][Full Text] [Related]
7. Effects of prostaglandin F2 alpha and a gonadotropin-releasing hormone agonist on inositol phospholipid metabolism in isolated rat corpora lutea of various ages.
Lahav M; West LA; Davis JS
Endocrinology; 1988 Aug; 123(2):1044-52. PubMed ID: 3293979
[TBL] [Abstract][Full Text] [Related]
8. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum.
Liu K; Olofsson JI; Wahlberg P; Ny T
Endocrinology; 1999 Nov; 140(11):5330-8. PubMed ID: 10537164
[TBL] [Abstract][Full Text] [Related]
9. Bovine membrane-type 1 matrix metalloproteinase: molecular cloning and expression in the corpus luteum.
Zhang B; Yan L; Moses MA; Tsang PC
Biol Reprod; 2002 Jul; 67(1):99-106. PubMed ID: 12080004
[TBL] [Abstract][Full Text] [Related]
10. An enzymologic study of corpora lutea in early pregnant rats treated with abortifacient agents.
Okazaki T; Okamura H; Motohashi T; Morikawa H; Yogo I
Fertil Steril; 1976 Aug; 27(8):980-6. PubMed ID: 955139
[TBL] [Abstract][Full Text] [Related]
11. Independent serum markers of corpora lutea function after gonadotropin-releasing hormone agonist trigger and adjuvant low dose human chorionic gonadotropin in in vitro fertilization.
Kaye L; Griffin D; Thorne J; Neuber E; Nulsen J; Benadiva C; Engmann L
Fertil Steril; 2019 Sep; 112(3):534-544. PubMed ID: 31227286
[TBL] [Abstract][Full Text] [Related]
12. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
Jo M; Thomas LE; Wheeler SE; Curry TE
Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase (2, 9, and 14) expression, localization, and activity in ovine corpora lutea throughout the estrous cycle.
Ricke WA; Smith GW; Reynolds LP; Redmer DA; Smith MF
Biol Reprod; 2002 Apr; 66(4):1083-94. PubMed ID: 11906929
[TBL] [Abstract][Full Text] [Related]
14. Effects of gonadotropin-releasing hormone agonist on human chorionic gonadotropin activity in granulosa cells of immature female rats.
Tungmahasuk D; Fungbun N; Laoharatchatathanin T; Terashima R; Kurusu S; Kawaminami M
J Reprod Dev; 2018 Apr; 64(2):129-134. PubMed ID: 29249775
[TBL] [Abstract][Full Text] [Related]
15. The effect of luteal "rescue" on the expression and localization of matrix metalloproteinases and their tissue inhibitors in the human corpus luteum.
Duncan WC; McNeilly AS; Illingworth PJ
J Clin Endocrinol Metab; 1998 Jul; 83(7):2470-8. PubMed ID: 9661630
[TBL] [Abstract][Full Text] [Related]
16. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
[TBL] [Abstract][Full Text] [Related]
17. Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: relationship between steroidogenesis and apoptosis.
Andreu C; Parborell F; Vanzulli S; Chemes H; Tesone M
Mol Reprod Dev; 1998 Nov; 51(3):287-94. PubMed ID: 9771649
[TBL] [Abstract][Full Text] [Related]
18. Serum progesterone concentrations associated with superovulation and premature corpus luteum failure in dairy goats.
Stubbings RB; Bosu WT; Barker CA; King GJ
Can J Vet Res; 1986 Jul; 50(3):369-73. PubMed ID: 3742374
[TBL] [Abstract][Full Text] [Related]
19. [Studies on the activities of steroidogenic enzymes in corpora lutea of early pregnant rats treated with abortifacient drugs (author's transl)].
Okazaki T
Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):813-24. PubMed ID: 1241845
[TBL] [Abstract][Full Text] [Related]
20. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
Valbuena D; Pellicer A; Guanes PP; Remohí J; Simón C
Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
